Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

BACKGROUND: Anti–vascular endothelial growth factor (anti-VEGF) agents have become the standard of care in neovascular age-related macular degeneration (nAMD). Despite generally excellent response rates to anti-VEGF therapy, some patients do not respond or may respond suboptimally. In the case of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Razavi, Sam, Kodjikian, Laurent, Giocanti-Aurégan, Audrey, Dufour, Ingrid, Souied, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890834/
https://www.ncbi.nlm.nih.gov/pubmed/33596867
http://dx.doi.org/10.1186/s12886-021-01841-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890834/
https://www.ncbi.nlm.nih.gov/pubmed/33596867
http://dx.doi.org/10.1186/s12886-021-01841-6

Ejemplares similares